LXEO Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 20:54):
Our systems believe the stock currently is undervalued by 0.05% compare to its pairs and should correct upwards.

Stats
Dagens volum	52 119
Gjennomsnittsvolum	145 361
Markedsverdi	507.52M
EPS	$-0.770 ( Q1 \| 2024-03-31 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0860 (0.56%)

AADI -7.02%

ABCL 1.47%

ABCM 0.04%

ABEO -3.55%

ABIO -1.68%

ABOS 3.74%

ABSI 4.08%

ABUS -0.98%

ABVX -3.00%

ACAD -0.16%

ACER -17.95%

ACET -8.86%

ACGN 1.29%

ACHL -2.48%

ACHV 3.88%

ACIU -1.25%

ACLX -0.16%

ACRV -5.61%

ACST -1.68%

ACXP 3.92%

ADAG 6.07%

ADAP -2.53%

ADGI 0.87%

ADIL -1.70%

ADMA -1.86%

ADPT 0.74%

ADTX -2.78%

ADVM 1.09%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -3.04%

AGIO -1.99%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.15%

AKRO -2.53%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.00%

ALGS 1.32%

ALKS 1.80%

ALLK -11.49%

ALLO -4.16%

ALLR -1.49%

ALNA 3.16%

ALNY 2.21%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -13.50%

ALVR -0.69%

ALXN 0.00%

ALXO -13.55%

ALZN 4.02%

AMRN -2.51%

AMTI -3.13%

ANAB 1.17%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 2.18%

ANPC -3.15%

APGE 0.64%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.94%

APLT -0.56%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.24%

ARDS -12.13%

ARDX 0.83%

ARGX -0.43%

ARNA 0.00%

ARPO -0.90%

ARQT -2.97%

ARTL -2.50%

ARTLW 0.00%

ARVN 8.46%

ARWR -1.75%

ASLN -3.43%

ASMB -4.22%

ASND -1.93%

ATAI -4.80%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.26%

ATRA -3.60%

ATXI 2.70%

ATXS -1.22%

AUPH -1.08%

AURA 4.55%

AUTL -3.30%

AVBP -4.02%

AVEO 0.00%

AVIR -2.19%

AVRO -1.41%

AVTE -0.34%

AVTX -3.74%

AVXL -4.93%

AXLA 0.00%

AXSM -1.32%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.95%

BCAB -3.92%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.48%

BCRX 1.89%

BCTX 10.31%

BCTXW 13.02%

BCYC 0.85%

BDRX -4.06%

BDTX 0.00%

BEAM 2.35%

BFRA -2.91%

BGNE -2.25%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.46%

BLTE -1.13%

BLU 0.03%

BLUE -2.08%

BMEA -13.79%

BMRN 0.42%

BNOX 6.15%

BNTC -2.99%

BNTX -1.86%

BOLD -7.90%

BOLT -0.05%

BPMC -1.45%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -5.19%

BTAI 11.86%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 2.01%

CADL 0.71%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -0.86%

CARA -3.29%

CARM 6.93%

CASI 4.08%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.76%

CCXI 0.00%

CDAK 0.00%

CDIO -3.06%

CDIOW 24.00%

CDMO -1.27%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.58%

CDXS 9.61%

CELC -3.25%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.28%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.24%

CGEN -3.31%

CGON -1.40%

CGTX -4.35%

CHMA -6.00%

CHRS 4.11%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -1.08%

CLGN 0.00%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.41%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.61%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.51%

CNCE 0.00%

CNSP -35.23%

CNST 0.00%

CNTA 0.51%

CNTB -0.75%

CNTX -5.48%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.60%

COYA -0.49%

CPRX -1.78%

CRBP -0.78%

CRBU -7.10%

CRDF 1.10%

CRGX -0.03%

CRIS -1.59%

CRNX -6.20%

CRSP -0.05%

CRTX 2.63%

CRVO -3.95%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.31%

CUE -3.11%

CVAC -7.49%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.55%

CYTO 0.00%

DARE 3.54%

DAWN -1.19%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.39%

DNLI -2.05%

DNTH -6.31%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -3.12%

EDSA 4.09%

EFTR 4.47%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.47%

ELEV -1.66%

ELOX 10.77%

ELTX -5.15%

ELVN -1.84%

ELYM 5.09%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.65%

ENTO -4.97%

ENTX -0.53%

ENVB 4.72%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 1.20%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.07%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.26%

EVLO 0.00%

EWTX -0.92%

EXAI -0.47%

EXEL 0.56%

EYEG -0.69%

EYEN 0.00%

EYPT 1.21%

FATE -11.83%

FBIO 0.65%

FBIOP 0.87%

FBLG -4.80%

FBRX -0.02%

FDMT -4.93%

FENC -2.51%

FGEN -9.79%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.42%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.33%

FULC 1.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.67%

GANX -3.08%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.10%

GHRS -3.72%

GLMD -4.09%

GLPG -1.52%

GLSI 5.01%

GLTO -3.31%

GLUE -3.69%

GLYC -12.27%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.66%

GNPX -3.40%

GNTA 3.94%

GOSS -9.46%

GOVX -1.37%

GOVXW 10.89%

GPCR -6.49%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.69%

GRTX -1.66%

GTHX 1.59%

GUTS 1.40%

GXGXW 41.67%

GYRE -4.54%

HALO -1.60%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -1.30%

HOOK 1.99%

HOTH -0.55%

HOWL 1.92%

HRMY 3.06%

HRTX 8.36%

HSTO 0.00%

HUMA 1.42%

HUMAW -6.26%

IBRX -5.85%

ICCC -3.10%

ICPT 0.21%

ICU 14.82%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.11%

IFRX -2.78%

IGMS -1.02%

IKNA -0.30%

IKT -9.93%

IMAB 0.00%

IMCR -3.39%

IMGN 0.02%

IMGO 0.00%

IMMP 5.13%

IMMX -6.90%

IMNM 4.33%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.25%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -3.33%

INAB -0.72%

INBX -2.78%

INCY -2.19%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 0.04%

INMB 4.68%

INO 2.72%

INSM -0.90%

INTS -1.96%

INVA 0.28%

INZY 2.17%

IOBT -9.60%

IONS 1.27%

IOVA -2.84%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.41%

ISEE 0.38%

ITOS 1.30%

ITRM 2.33%

IVA 6.96%

IVVD 0.00%

JAGX 1.57%

JANX -4.46%

JAZZ -0.96%

JNCE 0.00%

JSPR -1.90%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.29%

KDNY 0.22%

KMPH -0.34%

KNSA -1.90%

KNTE -0.38%

KOD -7.71%

KPRX -4.08%

KPTI -8.61%

KRBP -10.00%

KRON 1.58%

KROS -0.37%

KRRO -2.21%

KRTX 0.03%

KRYS 0.17%

KTRA 13.11%

KTTA -0.65%

KTTAW 0.92%

KURA 0.88%

KYMR -2.99%

KYTX -4.12%

KZIA 0.34%

KZR -0.20%

LABP 0.57%

LBPH -0.32%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.97%

LENZ -2.54%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA 0.24%

LRMR 0.21%

LSTA -1.68%

LTRN 5.85%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -1.77%

LYEL -35.05%

LYRA 1.98%

MACK 0.10%

MBIO -11.29%

MBRX -1.43%

MCRB 3.00%

MDGL -2.10%

MDNA -13.16%

MDWD 3.56%

MDXG -2.21%

MEIP 0.00%

MESO -1.49%

MGNX -5.13%

MGTA -7.74%

MGTX -0.95%

MGX 2.14%

MIRM 0.63%

MIRO 0.59%

MIST 3.09%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX 0.13%

MLYS -6.08%

MNKD -0.67%

MNMD 3.25%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.42%

MORF -3.40%

MREO 0.00%

MRKR -0.43%

MRNA -9.20%

MRNS -5.50%

MRSN -2.86%

MRTX -0.17%

MRUS -0.35%

MRVI 0.07%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.03%

MYMD 1.08%

NAMS 0.34%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 8.31%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.79%

NKGN 9.85%

NKGNW -18.03%

NKTR 3.74%

NKTX -3.59%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.37%

NMTR -42.97%

NOVN -24.84%

NRBO 14.80%

NRIX -0.63%

NRSN -4.82%

NRSNW 0.00%

NRXP -7.81%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.33%

NTRBW -31.07%

NUVL -0.95%

NVAX -7.90%

NVCT -7.54%

NVIV -34.28%

NXTC -5.29%

NYMX -0.05%

OABI 2.77%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.80%

OCGN 8.55%

OCS -1.00%

OCUL 1.14%

OCUP 0.65%

ODT -4.27%

OKYO 1.72%

OLMA -4.86%

OMER -2.31%

OMGA 0.42%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -1.78%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.25%

OVID 0.30%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.70%

PCSA -1.93%

PCVX 0.01%

PDSB -6.38%

PEPG 1.19%

PGEN -6.29%

PHAR 2.19%

PHAS 0.00%

PHAT -0.77%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.11%

PLUR 7.39%

PMN -5.55%

PMVP -2.68%

PNT 0.16%

PPBT -6.87%

PRAX 7.28%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK -0.45%

PRQR 1.17%

PRTA -2.84%

PRTC 0.62%

PRTG 4.13%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.91%

PTCT -0.77%

PTE -0.82%

PTGX -1.14%

PTIXW -48.41%

PULM 1.57%

PXMD 4.76%

PYPD 1.71%

PYXS 3.92%

QLGN -2.78%

QNCX 5.70%

QNRX 3.40%

QSI -32.13%

QSIAW -3.13%

QTTB 1.83%

QURE -0.67%

RAIN -1.63%

RANI 4.81%

RAPT -1.62%

RARE 2.08%

RCKT -9.85%

REGN -0.30%

RENB -3.73%

REPL -1.81%

RETA 0.02%

REUN -0.89%

REVB -1.86%

REVBU 3.46%

REVBW 5.00%

RGLS -5.79%

RGNX -6.66%

RIGL -6.25%

RLAY -4.67%

RLMD 0.00%

RLYB -4.70%

RNA 1.98%

RNAC -4.53%

RNAZ -0.96%

RNXT 1.79%

ROIV -1.75%

ROIVW 4.56%

RPHM -1.40%

RPRX -0.59%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.62%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.98%

RYTM -6.15%

RYZB 0.02%

RZLT 3.62%

SABS -1.37%

SABSW -11.81%

SAGE -0.09%

SANA -2.49%

SAVA -1.81%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -3.85%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.48%

SGMT -5.80%

SGTX -2.56%

SIOX 22.63%

SLDB -2.59%

SLGL 5.23%

SLN -6.92%

SLNO 0.65%

SLRX 1.21%

SLS -2.56%

SMMT -3.31%

SNDX 3.27%

SNGX -0.38%

SNPX -0.46%

SONN -2.15%

SPPI -0.49%

SPRB -1.36%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -0.97%

SRRA 0.00%

SRRK -1.61%

SRZN -2.45%

STAB 0.00%

STOK -7.24%

STRO -2.68%

STSA 0.00%

STTK 6.61%

SURF -0.93%

SVRA -0.39%

SWTX -0.22%

SYBX 1.29%

SYRS -1.89%

TALS -0.73%

TARA -7.36%

TARS -1.53%

TBPH 0.71%

TCBP 9.84%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -1.75%

TCRX 4.69%

TECH -0.79%

TENX -0.32%

TERN -8.41%

TFFP -7.61%

TGTX -7.09%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -6.26%

TNGX -3.24%

TNXP -7.17%

TNYA -4.03%

TPST 5.83%

TRDA -4.67%

TRVI 2.68%

TRVN 0.82%

TSHA -18.90%

TSVT -3.99%

TTNP -6.05%

TVTX 3.39%

TYRA -6.77%

UBX -2.13%

UNCY -4.00%

URGN 2.46%

UTHR -0.14%

VACC 11.36%

VALN -6.70%

VAXX 106.25%

VBIV 0.93%

VBLT -8.77%

VCEL 1.09%

VCNX 8.60%

VCYT -0.84%

VERA -5.31%

VERU 2.37%

VERV -2.58%

VIGL -1.08%

VINC 2.93%

VIR -0.98%

VIRI -5.72%

VIRX 3.98%

VKTX -1.72%

VLON -13.04%

VNDA -3.91%

VOR -5.69%

VRCA 0.00%

VRDN -3.84%

VRNA -1.73%

VRPX 1.02%

VRTX 0.08%

VSTM 4.24%

VTGN -1.25%

VTVT 0.39%

VTYX -2.72%

VXRT -1.78%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -2.72%

WVE -9.33%

XBIO 1.03%

XBIT 6.65%

XCUR 3.77%

XENE -1.74%

XERS 4.76%

XFOR 4.71%

XLO 4.42%

XLRN 0.00%

XNCR 0.47%

XOMA -9.20%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.79%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-11-07	Omega Fund Vi, L.p.	Buy	454 545	Common Stock
2023-11-07	Omega Fund Vi, L.p.	Buy	287 213	Common Stock
2023-11-07	Omega Fund Vi, L.p.	Buy	1 415 865	Common Stock
2023-11-07	Omega Fund Vi, L.p.	Sell	2 615 533	Series B convertible preferred stock
2023-11-07	Omega Fund Vi, L.p.	Sell	14 999 999	Series A convertible preferred stock

INSIDER POWER
-79.48
Last 16 transactions
Buy: 4 724 723 \| Sell: 41 348 236

Korrelasjon (AI algo v.1.1b): Undervalued: 0.05% $15.41 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.20 (neutral)

Kort: 0.48 (neutral)

Signal:(47.954) Neutral

Lexeo Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Lexeo Therapeutics, Inc. Korrelasjon - Valuta/Råvare

-0.71
( moderate negative )

-0.45
( neutral )

0.00
( neutral )

-0.55
( weak negative )

0.00
( neutral )

-0.36
( neutral )

Lexeo Therapeutics, Inc. Økonomi

Annual	2022
Omsetning:	$654 000
Bruttogevinst:	$654 000 (100.00 %)
EPS:	$-2.40

FY	2022
Omsetning:	$654 000
Bruttogevinst:	$654 000 (100.00 %)
EPS:	$-2.40

Financial Reports:

No articles found.

Lexeo Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich\'s ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.